| 1 |
35099408 | Stress hormone norepinephrine incites resistance of oral cancer cells to chemotherapy. | 2022 Mar 5 |
2 |
| 2 |
33487222 | Retraction notice to 'The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells' [EBioMedicine 35 (2018) 204-221]. | 2021 Jan |
2 |
| 3 |
34123574 | Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness. | 2021 Jun 1 |
1 |
| 4 |
34566636 | Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors. | 2021 |
1 |
| 5 |
31736281 | Methylation of drug resistance-related genes in chemotherapy-sensitive Epstein-Barr virus-associated gastric cancer. | 2020 Jan |
1 |
| 6 |
32012401 | Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma. | 2020 Apr |
1 |
| 7 |
32173903 | Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression. | 2020 Jun |
1 |
| 8 |
32724354 | MICA enhances sensitivity to cisplatin in patients with extensive small cell lung cancer via downregulation of ABCG2. | 2020 Aug |
1 |
| 9 |
33123242 | Synergistic antitumor effect of dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with cisplatin on drug-resistant non-small cell lung cancer cell. | 2020 Dec |
1 |
| 10 |
33133187 | Corrigendum to "UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells". | 2020 |
1 |
| 11 |
33227065 | AKT isoforms have discrete expression in triple negative breast cancers and roles in cisplatin sensitivity. | 2020 Nov 10 |
3 |
| 12 |
30675218 | NOS1 upregulates ABCG2 expression contributing to DDP chemoresistance in ovarian cancer cells. | 2019 Feb |
2 |
| 13 |
30693031 | UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells. | 2019 |
1 |
| 14 |
30697056 | Scutellarin inhibits the metastasis and cisplatin resistance in glioma cells. | 2019 |
1 |
| 15 |
31426474 | The Cisplatin-Derived Increase of Mitochondrial Reactive Oxygen Species Enhances the Effectiveness of Photodynamic Therapy via Transporter Regulation. | 2019 Aug 17 |
3 |
| 16 |
31762812 | Downregulated Salt-inducible Kinase 3 Expression Promotes Chemoresistance in Serous Ovarian Cancer via the ATP-binding Cassette Protein ABCG2. | 2019 |
1 |
| 17 |
31819528 | Differential Expression And Effects Of Peroxiredoxin-6 On Drug Resistance And Cancer Stem Cell-Like Properties In Non-Small Cell Lung Cancer. | 2019 |
1 |
| 18 |
31915416 | Interleukin-7 Resensitizes Non-Small-Cell Lung Cancer to Cisplatin via Inhibition of ABCG2. | 2019 |
1 |
| 19 |
29552151 | Rab23 promotes the cisplatin resistance of ovarian cancer via the Shh-Gli-ABCG2 signaling pathway. | 2018 Apr |
1 |
| 20 |
29876362 | Negative Regulation of PTEN by MicroRNA-221 and Its Association with Drug Resistance and Cellular Senescence in Lung Cancer Cells. | 2018 |
1 |
| 21 |
30002682 | DSPP-MMP20 gene silencing downregulates cancer stem cell markers in human oral cancer cells. | 2018 |
1 |
| 22 |
30146342 | The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells. | 2018 Sep |
2 |
| 23 |
28340578 | ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling. | 2017 Mar 24 |
5 |
| 24 |
28383763 | Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway. | 2017 Sep |
2 |
| 25 |
28639895 | Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1+ colorectal cancer stem cells. | 2017 Jun |
3 |
| 26 |
26513225 | Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling. | 2016 Nov |
1 |
| 27 |
27221310 | Upregulation of ABCG2 via the PI3K-Akt pathway contributes to acidic microenvironment-induced cisplatin resistance in A549 and LTEP-a-2 lung cancer cells. | 2016 Jul |
1 |
| 28 |
27247490 | Silencing of ABCG2 by MicroRNA-3163 Inhibits Multidrug Resistance in Retinoblastoma Cancer Stem Cells. | 2016 Jun |
1 |
| 29 |
25603057 | Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung adenocarcinoma. | 2015 Feb 20 |
1 |
| 30 |
25940289 | [Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells]. | 2015 May |
1 |
| 31 |
26517090 | Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential. | 2015 Dec 29 |
1 |
| 32 |
25083297 | Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based chemotherapy. | 2014 Aug |
3 |
| 33 |
25200103 | ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines. | 2014 Nov |
2 |
| 34 |
22974371 | Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma. | 2013 Feb 15 |
2 |
| 35 |
23135908 | Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. | 2013 Jan 1 |
1 |
| 36 |
23301671 | Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2. | 2013 Jul |
1 |
| 37 |
23381786 | Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells. | 2013 Apr |
3 |
| 38 |
23416969 | The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics. | 2013 Apr |
2 |
| 39 |
23876835 | Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway. | 2013 Oct |
1 |
| 40 |
23996530 | Transcription factors Sp1 and Sp3 regulate expression of human ABCG2 gene and chemoresistance phenotype. | 2013 Oct |
1 |
| 41 |
24151392 | Role of ABCG2 expression driven by cisplatin in platinum-containing chemotherapy for gastric cancer. | 2013 Oct 21 |
3 |
| 42 |
21678497 | Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells. | 2012 Jun |
1 |
| 43 |
22544328 | Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype. | 2012 May 15 |
1 |
| 44 |
22701315 | Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs. | 2012 |
1 |
| 45 |
22750060 | OSI-930 analogues as novel reversal agents for ABCG2-mediated multidrug resistance. | 2012 Sep 15 |
3 |
| 46 |
22844424 | Low molecular weight heparin ablates lung cancer cisplatin-resistance by inducing proteasome-mediated ABCG2 protein degradation. | 2012 |
1 |
| 47 |
21215350 | Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies. | 2011 Apr |
1 |
| 48 |
21342274 | Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. | 2011 Sep |
1 |
| 49 |
20596671 | Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed. | 2010 Aug |
1 |
| 50 |
20628484 | Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line. | 2010 |
2 |